# HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

> **NCT02038335** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 451 (actual)

## Conditions studied

- Contraception
- HIV
- Immune Cells (Mucosal and Systemic)
- Microbiota

## Interventions

- **DRUG:** DMPA
- **DRUG:** NET-EN
- **DRUG:** MPA/E2
- **DEVICE:** LNG-I
- **DEVICE:** ENG-I
- **DEVICE:** Cu-IUD

## Key facts

- **NCT ID:** NCT02038335
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-06
- **Final completion:** 2020-12
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2020-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02038335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02038335, "HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02038335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*